ifenprodil

This page covers all ifenprodil drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Glutamate receptor ionotropic, NMDA 2A, Glutamate receptor ionotropic, NMDA 2B, Glutamate receptor ionotropic, NMDA 2C.

Targets

Glutamate receptor ionotropic, NMDA 2A, Glutamate receptor ionotropic, NMDA 2B, Glutamate receptor ionotropic, NMDA 2C

Phase 2 pipeline (1)

• IFENPRODIL · Neuroscience
  IFENPRODIL works by selectively blocking the Sigma non-opioid intracellular receptor 1.

Patent intelligence

• ifenprodil patent landscape — aggregated cliff calendar, attackable patents, originator estates